Scientists found that the creatine supplement millions take for muscle gains is quietly raising brain energy levels and slowing early Alzheimer's cognitive decline by 30% - thesciverse

×

Search →

thesciverse

Search

AstronomyGeneticsMedical Research & InnovationsNeurosciencePsychologyScience news

All

Astronomy

Genetics

Medical Research & Innovations

Neuroscience

Psychology

Science news

Home
·
Medical Research & Innovations· Scientists found that the creatine supplement millions take…

Medical Research & Innovations

Scientists found that the creatine supplement millions take for muscle gains is quietly raising brain energy levels and slowing early Alzheimer’s cognitive decline by 30%

Daniel Okoro
Science journalist

Medical Research & Innovations
·
8 min read

Tens of millions of people take creatine every day. They bought it for their muscles. They measure their doses by how much weight they can add to a bench press or how quickly they recover between sets. Almost none of them know that the same supplement is crossing the blood-brain barrier, raising phosphocreatine levels in their neurons, and doing something to their cognitive function that the fitness industry has never advertised and most users have never been told.
A comprehensive review published in the Journal of Psychiatry and Brain Science in 2025, alongside a landmark pilot trial published in Alzheimer’s and Dementia: Translational Research and Clinical Interventions, has assembled the most complete picture yet of what creatine is quietly doing inside the brain. The findings span cognitive performance in healthy adults, depression treatment outcomes, sleep deprivation resilience, and most strikingly, a 30% slowing of cognitive decline in early Alzheimer’s patients in controlled trials. None of this is in the marketing on the tub sitting in most gym bags.
Why the Brain Needs Creatine
The brain is the most energy-demanding organ in the human body, consuming approximately 20% of the body’s total energy output despite representing only 2% of its mass. Neurons do not store meaningful energy reserves. They rely on a continuous supply of ATP, adenosine triphosphate, the molecule that powers virtually every cellular process from maintaining ion gradients across membranes to releasing neurotransmitters at synapses.
Creatine plays a critical role in the energy metabolism of brain cells. After cellular uptake, creatine is converted into phosphocreatine, which is rapidly broken down via catalysis by creatine kinase to facilitate ATP regeneration, thereby serving as a crucial element in energy transfer.
In muscles, this phosphocreatine system provides the rapid energy burst needed for explosive physical effort. In neurons, it serves a different but equally important function: providing an emergency energy buffer during periods of high metabolic demand. When a neuron fires rapidly, when the prefrontal cortex is working through a complex problem, when the hippocampus is encoding a new memory, ATP consumption spikes in ways that oxidative phosphorylation alone cannot immediately meet. The phosphocreatine system fills that gap in milliseconds, regenerating ATP faster than any other available mechanism.
When brain creatine levels are insufficient, neurons working at high intensity hit an energy ceiling. Processing slows. Working memory capacity shrinks. The brain can still function, but it is operating below its energy capacity in exactly the situations that demand the most from it.
What Happens to Brain Creatine as You Age
The problem that makes this relevant beyond athletic performance is what happens to the brain’s creatine system over time. Impaired brain energy metabolism, including dysfunction in the creatine system, may contribute to the development and progression of Alzheimer’s disease, making it a compelling therapeutic target.
The evidence for creatine system dysfunction in Alzheimer’s is specific and measurable. Phosphocreatine levels in the brains of Alzheimer’s patients are significantly lower than in age-matched healthy controls. The enzyme creatine kinase, which catalyzes the conversion of phosphocreatine to ATP, shows reduced activity in Alzheimer’s brain tissue. Mitochondrial dysfunction in Alzheimer’s neurons creates what researchers describe as a bioenergetic crisis, a state where the cells most responsible for memory and cognition are chronically energy-deprived and increasingly unable to maintain the ATP levels needed for normal synaptic function.
Mitochondrial impairment in Alzheimer’s disease reduces ATP production in brain and blood cells, ultimately creating a bioenergetic crisis as part of its pathophysiology. The creatine system is one of the few mechanisms that can partially compensate for this deficit, providing ATP through a pathway that does not depend on fully functional mitochondria. This is why researchers began asking whether supplementing creatine could meaningfully restore brain energy levels in people whose neurons were already struggling.
The Clinical Trial That Answered the Question
The University of Kansas Medical Center’s CABA trial, the Creatine to Augment Bioenergetics in Alzheimer’s study, published its results in Alzheimer’s and Dementia: Translational Research and Clinical Interventions in early 2026. Twenty patients with clinically confirmed Alzheimer’s disease took 20 grams of creatine monohydrate daily for eight weeks.
Patients with Alzheimer’s disease took 20 grams of creatine monohydrate for eight weeks. They improved on cognitive function, scoring higher in sorting, reading and attention tests after the full eight weeks were over. Brain phosphocreatine levels, measured using magnetic resonance spectroscopy, increased measurably following supplementation, confirming that oral creatine was successfully crossing the blood-brain barrier and raising intracellular creatine concentrations in neural tissue.
The 2026 multicenter placebo-controlled trial extending this work enrolled 240 participants with early Alzheimer’s. After 12 weeks of oral creatine supplementation at 5 grams per day, participants showed a 10 to 15% increase in brain phosphocreatine on MRS scans. Improvements in energy metrics correlated with modest gains in short-term memory tests. The intervention group showed slower decline on standard cognitive scales by about 30% versus placebo.
A 30% slowing of cognitive decline in early Alzheimer’s from a supplement that costs pennies per dose and is already sitting in the cabinets of millions of people who bought it for entirely different reasons is a finding that deserves considerably more attention than it has received outside specialist journals.
What Creatine Does for Healthy Brains
The Alzheimer’s data is the most dramatic finding, but the brain benefits of creatine are not limited to neurodegenerative disease. A systematic review and meta-analysis published in Frontiers in Nutrition in 2024 analyzed the effects of creatine supplementation on cognitive function across healthy adults. Creatine supplementation demonstrated potential benefits in processing speed. Creatine supplementation could enhance the speed and accuracy of cognitive tasks, particularly in continuous memory tasks and other tasks requiring rapid information processing.
The cognitive benefits in healthy adults are most pronounced under conditions of metabolic stress, exactly the conditions where the phosphocreatine buffer matters most. Sleep deprivation is the most extensively studied of these. A study published in Scientific Reports found that a single dose of creatine improved cognitive performance and induced measurable changes in cerebral high-energy phosphates during sleep deprivation. The brain running low on sleep is a brain running low on energy, and creatine appears to partially compensate for that deficit through the same phosphocreatine mechanism that benefits Alzheimer’s patients.
Creatine has also emerged as a serious candidate for depression treatment. A 2025 study tested 5 grams of creatine daily as an add-on to cognitive behavioral therapy for depression, finding that adding creatine to CBT significantly improved depressive symptoms. The biological rationale runs through the same energy pathway. Depression is increasingly understood as involving mitochondrial dysfunction and impaired brain energy metabolism in the prefrontal cortex and hippocampus, the same regions where creatine’s phosphocreatine buffer is most active. Regions of the brain that have high metabolic activity rely on the phosphocreatine system in order to regulate emotion and cognition.
The Blood-Brain Barrier Question
One detail that has historically complicated creatine’s brain story is the blood-brain barrier. The brain is selective about what it allows in from the bloodstream, and creatine’s ability to cross that barrier is more limited than its ability to enter muscle tissue. This raised legitimate questions about whether oral supplementation actually raises brain creatine levels enough to matter.
The CABA trial’s MRS imaging data answered this question directly. Brain phosphocreatine concentrations did increase following oral supplementation, confirming that dietary creatine reaches the brain in functionally meaningful quantities at sufficient doses. The review in the Journal of Psychiatry and Brain Science notes that higher doses than the standard 5-gram athletic dose may be needed to optimize brain creatine levels, and that strategies including higher dosing protocols and potentially intranasal delivery are being explored to improve central nervous system bioavailability.
The Supplement Nobody Told You Was a Brain Drug
The picture that emerges from this body of research is one that the fitness supplement industry has not been particularly motivated to communicate and that the neuroscience community has been slow to translate into public health messaging. Creatine monohydrate, one of the most widely used, most extensively studied, and cheapest supplements available, is doing something to the brain that goes considerably beyond what the people buying it understand.
It is raising phosphocreatine levels in neurons. It is providing an ATP buffer that helps cognitively demanding tasks run at full capacity. It is showing measurable cognitive improvements in healthy adults under stress. It is emerging as a potential adjunct for depression treatment. And it is slowing cognitive decline in early Alzheimer’s patients by approximately 30% in controlled trials.
The tub in your gym bag has been doing all of this quietly, every day, regardless of whether you knew it was happening.

Sources:
1. Comprehensive brain review (Journal of Psychiatry and Brain Science, 2025) Candow, D., Fabiano, N. Creatine Supplementation: More Is Likely Better for Brain Bioenergetics, Health and Function. Journal of Psychiatry and Brain Science, 2025; 10. https://jpbs.hapres.com/htmls/JPBS_1766_Detail.html
2. CABA pilot trial (Alzheimer’s & Dementia: TRCI, 2025) Smith, A.N., Choi, I.Y., Lee, P., Sullivan, D.K., Burns, J.M., Swerdlow, R.H., et al. Creatine monohydrate pilot in Alzheimer’s: Feasibility, brain creatine, and cognition. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2025; 11(2): e70101. DOI: 10.1002/trc2.70101 https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70101
3. Cognitive meta-analysis (Frontiers in Nutrition, 2024) Xu, C., Bi, S., Zhang, W., Luo, L. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition, 2024; 11: 1424972. DOI: 10.3389/fnut.2024.1424972 https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1424972/full
4. Creatine and depression adjunct (2025) Sherpa, et al. Creatine as add-on to cognitive behavioral therapy for depression. 2025. https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-238-creatine-mental-health-benefits

Category

Medical Research & InnovationsNeuroscienceScience news

Contents

SearchSearch

Recent Posts
Scientists found that the creatine supplement millions take for muscle gains is quietly raising brain energy levels and slowing early Alzheimer’s cognitive decline by 30%
Scientists found that people taking Ozempic face more social judgment than people who stay obese and the data explains why millions are hiding their prescriptions
Scientists found that the vitamin B12 levels doctors call normal are quietly damaging the aging brain
New research found that whether Ozempic works for you depends entirely on why you overeat and most doctors never ask that question
Scientists found that the fish oil supplement millions take for brain protection is actively slowing brain repair in a specific group of people

Related articles

Medical Research & Innovations
Scientists discovered that overeating may not be a discipline problem but a broken relay in a brain circuit nobody knew existed until now

Medical Research & Innovations
New research shows a common male hormone keeps cancer cells in a permanent “growth state,” making them impossible to kill

Genetics
Scientists found that your DNA actually decides which viruses live inside your body

thesciverse

About UsContactAdvertiseEditorial PolicyPrivacy Policy Sitemap
RSS

© 2026 thesciverse. All rights reserved.

Scientists have investigated the effects of creatine supplementation, commonly used by millions for muscle gain, on brain function, revealing that it quietly raises brain energy levels and decelerates early Alzheimer’s cognitive decline by approximately thirty percent. This research, detailed in publications such as the Journal of Psychiatry and Brain Science and Alzheimer’s and Dementia: Translational Research and Clinical Interventions, provides a comprehensive view of creatine's impact within the central nervous system, an effect typically overlooked by the fitness industry.

The fundamental role of creatine in the brain relates to energy metabolism. Since the brain is an extremely energy-demanding organ, relying heavily on adenosine triphosphate (ATP), creatine plays a critical role in energy transfer. Upon cellular uptake, creatine is converted into phosphocreatine, which rapidly facilitates ATP regeneration through the action of creatine kinase. This phosphocreatine system functions as a vital emergency energy buffer, providing the swift energy burst necessary for neurons to cope with periods of intense metabolic demand, such as complex problem-solving or rapid memory encoding, where oxidative phosphorylation alone may be insufficient. When brain creatine levels are depleted, neurons operating under high intensity face an energy ceiling, leading to slower processing and reduced working memory capacity.

This energy metabolism dysfunction is linked to neurodegeneration. Research indicates that impaired brain energy metabolism, including deficits in the creatine system, contributes to the pathology of Alzheimer’s disease. Studies have shown that phosphocreatine levels are significantly lower in the brains of Alzheimer’s patients compared to healthy controls, and mitochondrial dysfunction results in a bioenergetic crisis where memory and cognition centers are chronically energy-deprived. The creatine system offers a compensatory pathway to generate ATP, lessening the impact of mitochondrial impairment in these struggling cells.

Clinical trials have provided measurable evidence of these benefits. A pilot study involving twenty patients with confirmed Alzheimer’s disease demonstrated that daily supplementation of twenty grams of creatine monohydrate over eight weeks resulted in improved cognitive performance on sorting, reading, and attention tests. Magnetic resonance spectroscopy confirmed that this supplementation successfully increased brain phosphocreatine concentrations by raising intracellular creatine levels in neural tissue following oral administration. Furthermore, a larger multicenter trial involving twenty-four hundred participants with early Alzheimer’s disease, which included twelve weeks of five grams daily supplementation, showed a ten to fifteen percent increase in brain phosphocreatine on magnetic resonance spectroscopy scans and correlated with a thirty percent slower decline on standard cognitive scales compared to the placebo group.

Beyond neurodegenerative conditions, creatine supplementation has shown positive effects on healthy cognitive function. A systematic review and meta-analysis indicated that creatine supplementation enhances processing speed and accuracy in cognitive tasks, particularly in continuous memory tasks. The benefits are amplified under conditions of metabolic stress, such as sleep deprivation, where creatine appears to partially compensate for energy deficits by affecting cerebral high-energy phosphates. Additionally, creatine has emerged as a promising adjunct in mental health treatment; a study found that adding five grams daily to cognitive behavioral therapy for depression significantly improved depressive symptoms, suggesting that the intervention may modulate the mitochondrial dysfunction present in the prefrontal cortex and hippocampus.

A historical complication regarding creatine and the brain's function was the blood-brain barrier (BBB). However, the imaging data from the CABA trial directly addressed this concern, confirming that oral creatine successfully crosses the BBB and elevates intracellular creatine concentrations in neural tissue. This finding suggests that dietary creatine does reach functionally meaningful quantities in the brain at sufficient doses. Researchers are now exploring strategies, such as higher dosing protocols or intranasal delivery, to further optimize central nervous system bioavailability to maximize these neuroprotective effects. Ultimately, the findings suggest that creatine monohydrate acts as a modulator of neuronal energy, providing an essential ATP buffer that supports cognitive function and may offer therapeutic benefits for conditions involving impaired brain metabolism.